ARCHIVES

European Commission Approves Subcutaneous Rituximab

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

In Brief: DeVita, Seffrin Head Committee advising Feinstein On National Cancer Revision

November 5, 1999

Clinton Endorses Legislation Preventing Genetic Discrimination

May 23, 1997

Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.

June 10, 2005

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

Nutrition Program Announcement Lists Suggested Areas For Research

September 22, 1978